Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Pancreatic Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04104672
What this trial is testing

Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies

Who this might be right for
Advanced Pancreatic Cancer
Arcus Biosciences, Inc. 196
Early research (Phase 1)Ended earlyNCT00585845
What this trial is testing

Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment

Who this might be right for
Malignant Epithelial MesotheliomaAdenocarcinoma of the PancreasCarcinoma, Non-Small-Cell Lung+1 more
Anza Therapeutics, Inc. 17
Not applicableEnded earlyNCT04077372
What this trial is testing

Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers

Who this might be right for
Gastrointestinal CancerColorectal CancerPancreatic Adenocarcinoma+6 more
Stanford University 12
Testing effectiveness (Phase 2)Study completedNCT00004087
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer

Who this might be right for
Colorectal CancerPancreatic Cancer
Garden State Cancer Center at the Center for Molecular Medicine and Immunology 15
Testing effectiveness (Phase 2)Study completedNCT01010126
What this trial is testing

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaEndometrial Serous Adenocarcinoma+42 more
National Cancer Institute (NCI) 252
Testing effectiveness (Phase 2)Study completedNCT01466036
What this trial is testing

Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

Who this might be right for
Carcinoid TumorPancreatic Neuroendocrine Tumor
Dana-Farber Cancer Institute 61
Testing effectiveness (Phase 2)UnknownNCT04415385
What this trial is testing

The Combination of Camrelizumab and Apatinib as Second-line Therapy for Advanced Pancreatic Carcinoma

Who this might be right for
Pancreatic Cancer
Zhejiang Cancer Hospital 48
Testing effectiveness (Phase 2)Study completedNCT02632448
What this trial is testing

LY2880070 in Participants With Advanced or Metastatic Cancer

Who this might be right for
Solid TumorsColorectal CancerBreast Cancer+9 more
Esperas Pharma Inc. 229
Testing effectiveness (Phase 2)Looking for participantsNCT06782555
What this trial is testing

Evofosfamide in Combination with Zalifrelimab and Balstilimab

Who this might be right for
Metastatic Prostate CancerMetastatic Head and Neck Squamous Cell CarcinomaMetastatic Pancreatic Cancer
ImmunoGenesis 71
Not applicableStudy completedNCT02704143
What this trial is testing

Combination of SBRT With Sequential S-1 for Treating Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Changhai Hospital 63
Early research (Phase 1)Study completedNCT02227940
What this trial is testing

Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmALK PositiveMetastatic Pancreatic Adenocarcinoma+2 more
Roswell Park Cancer Institute 38
Early research (Phase 1)Ended earlyNCT05657418
What this trial is testing

A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Shanghai Junshi Bioscience Co., Ltd. 8
Not applicableLooking for participantsNCT06026943
What this trial is testing

Alpha Radiation Emitters for the Treatment of Pancreatic Cancer for the Treatment of Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerUnresectable Pancreatic CancerPancreatic Adenocarcinoma
Alpha Tau Medical LTD. 15
Testing effectiveness (Phase 2)UnknownNCT03382340
What this trial is testing

IMX-110 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultAdvanced Solid TumorsPancreatic Cancer+2 more
Immix Biopharma Australia Pty Ltd 70
Not applicableStudy completedNCT03323489
What this trial is testing

Celiac Plexus Radio-Surgery for Pain Management

Who this might be right for
Advanced CancerPancreas CancerPain
Dr. Yaacov Lawrence 125
Early research (Phase 1)Study completedNCT05712889
What this trial is testing

Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 29
Not applicableStudy completedNCT00974610
What this trial is testing

Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.

Who this might be right for
Breast CancerColorectal CancerLung Cancer+2 more
Cancer Trials Ireland 803
Early research (Phase 1)Study completedNCT02503774
What this trial is testing

MEDI9447 Alone and in Combination With MEDI4736 in Adult Participants With Select Advanced Solid Tumors.

Who this might be right for
Solid Tumors
MedImmune LLC 192
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)WithdrawnNCT02159248
What this trial is testing

Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation

Who this might be right for
Pancreatic Cancer
Orlando Health, Inc.
Next Page